SaMD(Software as a Medical Device) 시장 : 배포 유형별, 용도별, 최종사용자별 : 세계 기회 분석과 산업 예측(2024-2033년)

Software as a Medical Device Market By Deployment Type , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,250,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,469,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

SaMD(Software as a Medical Device) 시장

SaMD(Software as a Medical Device) 시장은 2023년에 1,950만 달러로 평가되며, 2024-2033년 CAGR 17.3%로 성장하며, 2033년에는 9,620만 달러에 달할 것으로 예측됩니다.

SaMD(Software as a Medical Device)는 의료용으로 설계된 전용 소프트웨어로 하드웨어 의료기기 없이도 기능을 수행 할 수 있으며, 환자의 건강 데이터를 관리하고 건강 상태를 진단하고 치료법을 추천하는 데 도움을 줄 수 있습니다. 이 소프트웨어는 스마트폰 및 태블릿과 같은 범용 컴퓨팅 플랫폼에서 쉽게 액세스할 수 있으므로 다용도하고 쉽게 접근 할 수 있으며, SaMD의 주요 특징은 의료 목적을 독자적으로 달성 할 수있는 잠재력을 가지고있어 현대 의료 시스템의 범위와 효율성을 가속화 할 수 있다는 것입니다. 범위와 효율성을 가속화합니다.

원격의료 및 원격 환자 모니터링의 채택 증가는 SaMD(Software as a Medical Device) 시장의 주요 촉진요인입니다. 또한 식품의약국 및 유럽 연합과 같은 여러 규제기관의 지원은 SaMD에 대한 수요를 증가시키고 있습니다. 의료 서비스 프로바이더의 지원을 향상시키기 위해 임상 의사결정 지원 시스템(CDSS)을 통합하는 것이 시장의 새로운 동향이 되고 있으며, CDSS의 기능은 증거에 기반한 임상적 판단에 도움을 주어 진단 정확도를 높이고 치료 절차를 최적화하는 데 도움이 됩니다.

그러나 기존 의료 기록과 헬스케어 데이터를 SaMD에 통합하는 데 많은 시간과 비용이 소요되므로 SaMD(Software as a Medical Device) 시장 개척에 걸림돌로 작용하고 있습니다. 또한 미국 식품의약국(FDA)의 엄격한 규제 준수 요건, 시판 전 승인, 엄격한 품질 검사, 시판 후 조사, 사이버 보안 요건, 특정 소프트웨어 수정 및 업데이트 등 FDA의 규제 요건도 SaMD 개발자들에게 큰 도전이 되고 있습니다. 업데이트가 포함됩니다. 이러한 요구사항은 모두 SaMD의 신뢰성과 유효성을 보장하고 중요한 의료 데이터와 환자 기록의 유출을 방지하는 데 도움이 됩니다.

부문 리뷰

SaMD(Software as a Medical Device) 시장은 배포 유형, 용도, 최종사용자, 지역으로 분류됩니다. 배포 유형에 따라 시장은 클라우드 기반과 온프레미스로 나뉩니다. 용도에 따라 스크리닝 및 진단, 모니터링 및 경고, 만성질환 관리, 디지털 치료, 기타로 구분됩니다. 최종사용자에 따라 병원 및 클리닉, 홈케어 환경, 기타로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다.

주요 조사 결과

배치 유형별로 보면 클라우드 기반 부문이 SaMD(Software as a Medical Device) 시장을 주도하고 있습니다.

용도별로 보면 스크리닝 및 진단 분야가 높은 시장 점유율을 차지하고 있습니다.

최종사용자별로는 병원 및 클리닉이 높은 점유율을 차지하고 있습니다.

지역별로는 북미가 SaMD(Software as a Medical Device) 시장에서 가장 높은 매출을 창출하고 있습니다.

본 리포트로 가능한 커스터마이즈(추가 비용과 스케줄이 필요합니다.)

• 규제 가이드라인
• 클라이언트의 관심에 부응한 추가 기업 개요
• 국가별 또는 지역별 추가 분석 - 시장 규모와 예측
• 기업 개요의 확장 리스트
• 과거 시장 데이터
• 주요 기업 상세(소재지, 연락처, 공급업체/벤더 네트워크 등을 포함한 엑셀 형식)

목차

제1장 서론

제2장 개요

제3장 시장 구도

• 시장의 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter's Five Forces 분석
• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회

제4장 SaMD(Software as a Medical Device) 시장 : 배포 유형별

• 시장 개요
• 클라우드 기반
• 온프레미스

제5장 SaMD(Software as a Medical Device) 시장 : 용도별

• 시장 개요
• 스크리닝과 진단
• 모니터링과 경계체제
• 만성질환 관리
• 디지털 치료
• 기타

제6장 SaMD(Software as a Medical Device) 시장 : 최종사용자별

• 시장 개요
• 병원과 진료소
• 재택 의료
• 기타

제7장 SaMD(Software as a Medical Device) 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국 : SaMD(Software as a Medical Device) 시장
  • 캐나다 SaMD(Software as a Medical Device) 시장
  • 멕시코의 SaMD(Software as a Medical Device) 시장
• 유럽
  • 주요 시장 동향과 기회
  • 독일의 SaMD(Software as a Medical Device) 시장
  • 프랑스 SaMD(Software as a Medical Device) 시장
  • 영국의 SaMD(Software as a Medical Device) 시장
  • 이탈리아의 SaMD(Software as a Medical Device) 시장
  • 스페인의 SaMD(Software as a Medical Device) 시장
  • 기타 유럽의 SaMD(Software as a Medical Device) 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 일본의 SaMD(Software as a Medical Device) 시장
  • 중국 SaMD(Software as a Medical Device) 시장
  • 인도 SaMD(Software as a Medical Device) 시장
  • 호주 SaMD(Software as a Medical Device) 시장
  • 한국 SaMD(Software as a Medical Device) 시장
  • 기타 아시아태평양의 SaMD(Software as a Medical Device) 시장
• 라틴아메리카·중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질의 SaMD(Software as a Medical Device) 시장
  • 사우디아라비아의 SaMD(Software as a Medical Device) 시장
  • 남아프리카공화국 : SaMD(Software as a Medical Device) 시장
  • 기타 라틴아메리카·중동 및 아프리카의 SaMD(Software as a Medical Device) 시장

제8장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 10 기업의 제품 지도제작
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제9장 기업 개요

• MindMaze
• Siemens
• Biofourmis
• BrightInsight, Inc.
• 4S Information Systems Ltd,
• Viz.ai, Inc.
• F. Hoffmann-La Roche Ltd
• Koninklijke Philips N.V.,
• Orthogonal
• Zuhlke Engineering AG

KSA

영문 목차

영문목차

(SaMD) Software as a Medical Device Market

The (SaMD) software as a medical device market was valued at $19.5 million in 2023 and is projected to reach $96.2 million by 2033, growing at a CAGR of 17.3% from 2024 to 2033.

Software as a medical device (SaMD) is dedicated software designed for medical use through which functions are performed without the requirement of a hardware medical device. SaMD aids in managing patient health data, diagnosing health conditions, and recommending treatments. The software is highly versatile and accessible as it is easily accessible on general-purpose computing platforms such as smartphones and tablets. A key characteristic of SaMD is its potential to independently accomplish medical objectives, thereby accelerating the scope and efficiency of modern healthcare systems.

Increase in the adoption of telehealth and remote patient monitoring is a major driver of the (SaMD) software as a medical device market. In addition, support from several regulatory bodies such as the Food and Drug Administration and the European Union is boosting the demand for SaMD. To improve the healthcare providers' assistance, the incorporation of Clinical Decision Support Systems (CDSS) is an emerging trend in the market. The capabilities of CDSS help in making evidence-based clinical decisions, thereby enhancing diagnostic accuracy and optimizing treatment procedures.

However, the integration of existing medical records and healthcare data into SaMD is a time-consuming and costly process, hence hampering the development of the (SaMD) software as a medical device market. Furthermore, usage of the software is subject to rigorous regulatory compliance by the U.S. Food and Drug Administration (FDA), which presents significant challenges for the SaMD developers. The regulatory requirements of FDA include premarket approval, strict quality check, post-market surveillance, cybersecurity requirements, and specific software modifications & updates. All these requirements ensure the reliability and efficacy of SaMD, thus preventing compromise with critical health data and patient records.

Segment Review

The (SaMD) software as a medical device market is segmented into deployment type, application, end user, and region. On the basis of deployment type, the market is bifurcated into cloud based and on premise. Depending on application, it is divided into screening & diagnosis, monitoring & alerting, chronic disease management, digital therapeutics, and others. As per end user, it is classified into hospitals & clinics, home care settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of deployment type, the cloud-based segment dominates the (SaMD) software as a medical device market.

Depending on application, the screening & diagnosis segment accounts for a high market share.

As per end user, the hospitals & clinics segment acquires a high stake in the market.

Region wise, North America is the highest revenue generator in the (SaMD) software as a medical device market.

Competition Analysis

The major players operating in the global (SaMD) software as a medical device market include MindMaze , Siemens, Biofourmis, BrightInsight, Inc., 4S Information Systems Ltd, Viz.ai, Inc., F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Orthogonal, and Zuhlke Engineering AG. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Deployment Type

• Cloud Based
• On Premise

By Application

• Screening and Diagnosis
• Monitoring and Alerting
• Chronic Disease Management
• Digital Therapeutics
• Others

By End User

• Hospitals and Clinics
• Home Care Settings
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• MindMaze
• Siemens
• Biofourmis
• BrightInsight, Inc.
• 4S Information Systems Ltd,
• Viz.ai, Inc.
• F. Hoffmann-La Roche Ltd
• Koninklijke Philips N.V.,
• Orthogonal
• Zuhlke Engineering AG

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Deployment Type
• 4.2. Cloud Based
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. On Premise
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Application
• 5.2. Screening And Diagnosis
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Monitoring And Alerting
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Chronic Disease Management
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country
• 5.5. Digital Therapeutics
  • 5.5.1. Key Market Trends, Growth Factors and Opportunities
  • 5.5.2. Market Size and Forecast, By Region
  • 5.5.3. Market Share Analysis, By Country
• 5.6. Others
  • 5.6.1. Key Market Trends, Growth Factors and Opportunities
  • 5.6.2. Market Size and Forecast, By Region
  • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By End User
• 6.2. Hospitals And Clinics
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Home Care Settings
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country
• 6.4. Others
  • 6.4.1. Key Market Trends, Growth Factors and Opportunities
  • 6.4.2. Market Size and Forecast, By Region
  • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Deployment Type
  • 7.2.3. Market Size and Forecast, By Application
  • 7.2.4. Market Size and Forecast, By End User
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. Software as a Medical Device (SaMD) Market
    • 7.2.6.1. Market Size and Forecast, By Deployment Type
    • 7.2.6.2. Market Size and Forecast, By Application
    • 7.2.6.3. Market Size and Forecast, By End User
  • 7.2.7. Canada Software as a Medical Device (SaMD) Market
    • 7.2.7.1. Market Size and Forecast, By Deployment Type
    • 7.2.7.2. Market Size and Forecast, By Application
    • 7.2.7.3. Market Size and Forecast, By End User
  • 7.2.8. Mexico Software as a Medical Device (SaMD) Market
    • 7.2.8.1. Market Size and Forecast, By Deployment Type
    • 7.2.8.2. Market Size and Forecast, By Application
    • 7.2.8.3. Market Size and Forecast, By End User
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Deployment Type
  • 7.3.3. Market Size and Forecast, By Application
  • 7.3.4. Market Size and Forecast, By End User
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. Germany Software as a Medical Device (SaMD) Market
    • 7.3.6.1. Market Size and Forecast, By Deployment Type
    • 7.3.6.2. Market Size and Forecast, By Application
    • 7.3.6.3. Market Size and Forecast, By End User
  • 7.3.7. France Software as a Medical Device (SaMD) Market
    • 7.3.7.1. Market Size and Forecast, By Deployment Type
    • 7.3.7.2. Market Size and Forecast, By Application
    • 7.3.7.3. Market Size and Forecast, By End User
  • 7.3.8. UK Software as a Medical Device (SaMD) Market
    • 7.3.8.1. Market Size and Forecast, By Deployment Type
    • 7.3.8.2. Market Size and Forecast, By Application
    • 7.3.8.3. Market Size and Forecast, By End User
  • 7.3.9. Italy Software as a Medical Device (SaMD) Market
    • 7.3.9.1. Market Size and Forecast, By Deployment Type
    • 7.3.9.2. Market Size and Forecast, By Application
    • 7.3.9.3. Market Size and Forecast, By End User
  • 7.3.10. Spain Software as a Medical Device (SaMD) Market
    • 7.3.10.1. Market Size and Forecast, By Deployment Type
    • 7.3.10.2. Market Size and Forecast, By Application
    • 7.3.10.3. Market Size and Forecast, By End User
  • 7.3.11. Rest of Europe Software as a Medical Device (SaMD) Market
    • 7.3.11.1. Market Size and Forecast, By Deployment Type
    • 7.3.11.2. Market Size and Forecast, By Application
    • 7.3.11.3. Market Size and Forecast, By End User
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Deployment Type
  • 7.4.3. Market Size and Forecast, By Application
  • 7.4.4. Market Size and Forecast, By End User
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. Japan Software as a Medical Device (SaMD) Market
    • 7.4.6.1. Market Size and Forecast, By Deployment Type
    • 7.4.6.2. Market Size and Forecast, By Application
    • 7.4.6.3. Market Size and Forecast, By End User
  • 7.4.7. China Software as a Medical Device (SaMD) Market
    • 7.4.7.1. Market Size and Forecast, By Deployment Type
    • 7.4.7.2. Market Size and Forecast, By Application
    • 7.4.7.3. Market Size and Forecast, By End User
  • 7.4.8. India Software as a Medical Device (SaMD) Market
    • 7.4.8.1. Market Size and Forecast, By Deployment Type
    • 7.4.8.2. Market Size and Forecast, By Application
    • 7.4.8.3. Market Size and Forecast, By End User
  • 7.4.9. Australia Software as a Medical Device (SaMD) Market
    • 7.4.9.1. Market Size and Forecast, By Deployment Type
    • 7.4.9.2. Market Size and Forecast, By Application
    • 7.4.9.3. Market Size and Forecast, By End User
  • 7.4.10. South Korea Software as a Medical Device (SaMD) Market
    • 7.4.10.1. Market Size and Forecast, By Deployment Type
    • 7.4.10.2. Market Size and Forecast, By Application
    • 7.4.10.3. Market Size and Forecast, By End User
  • 7.4.11. Rest of Asia-Pacific Software as a Medical Device (SaMD) Market
    • 7.4.11.1. Market Size and Forecast, By Deployment Type
    • 7.4.11.2. Market Size and Forecast, By Application
    • 7.4.11.3. Market Size and Forecast, By End User
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Deployment Type
  • 7.5.3. Market Size and Forecast, By Application
  • 7.5.4. Market Size and Forecast, By End User
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil Software as a Medical Device (SaMD) Market
    • 7.5.6.1. Market Size and Forecast, By Deployment Type
    • 7.5.6.2. Market Size and Forecast, By Application
    • 7.5.6.3. Market Size and Forecast, By End User
  • 7.5.7. Saudi Arabia Software as a Medical Device (SaMD) Market
    • 7.5.7.1. Market Size and Forecast, By Deployment Type
    • 7.5.7.2. Market Size and Forecast, By Application
    • 7.5.7.3. Market Size and Forecast, By End User
  • 7.5.8. South Africa Software as a Medical Device (SaMD) Market
    • 7.5.8.1. Market Size and Forecast, By Deployment Type
    • 7.5.8.2. Market Size and Forecast, By Application
    • 7.5.8.3. Market Size and Forecast, By End User
  • 7.5.9. Rest of LAMEA Software as a Medical Device (SaMD) Market
    • 7.5.9.1. Market Size and Forecast, By Deployment Type
    • 7.5.9.2. Market Size and Forecast, By Application
    • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. MindMaze
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. Siemens
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. Biofourmis
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. BrightInsight, Inc.
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. 4S Information Systems Ltd,
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. Viz.ai, Inc.
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. F. Hoffmann-La Roche Ltd
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. Koninklijke Philips N.V.,
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. Orthogonal
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments
• 9.10. Zuhlke Engineering AG
  • 9.10.1. Company Overview
  • 9.10.2. Key Executives
  • 9.10.3. Company Snapshot
  • 9.10.4. Operating Business Segments
  • 9.10.5. Product Portfolio
  • 9.10.6. Business Performance
  • 9.10.7. Key Strategic Moves and Developments

관련자료